Frontiers P2RY12-Inhibitors Reduce Cancer-Associated Thrombosis and Tumor Growth in Pancreatic Cancers

Human Colorectal Cancer Cell Line Ht29 (ATCC), Bioz

CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma - ScienceDirect

Human Colorectal Cancer Cell Line Ht29 (ATCC), Bioz

P2Y12 Receptor Modulates Sepsis-Induced Inflammation

Neurotransmitter signaling: a new frontier in colorectal cancer biology and treatment

The role of coagulation and platelets in colon cancer-associated thrombosis

Cancer-associated venous thromboembolism

Tamoxifen Directly Inhibits Platelet Angiogenic Potential and Platelet-Mediated Metastasis

PDF) P2RY12-Inhibitors Reduce Cancer-Associated Thrombosis and Tumor Growth in Pancreatic Cancers

PDF) Antiplatelet Drug Ticagrelor Enhances Chemotherapeutic Efficacy by Targeting the Novel P2Y12-AKT Pathway in Pancreatic Cancer Cells

PDF) Antiplatelet Drug Ticagrelor Enhances Chemotherapeutic Efficacy by Targeting the Novel P2Y12-AKT Pathway in Pancreatic Cancer Cells